Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies

Author:

Timms John F.1,Arslan-Low Elif1,Kabir Musarat1,Worthington Jenny1,Camuzeaux Stephane1,Sinclair John1,Szaub Joanna1,Afrough Babak1,Podust Vladimir N.2,Fourkala Evangelia-Ourania1,Cubizolles Myriam2,Kronenberg Florian3,Fung Eric T.2,Gentry-Maharaj Aleksandra1,Menon Usha1,Jacobs Ian1

Affiliation:

1. EGA Institute for Women's Health; University College London; London UK

2. Vermillion Inc. (formerly Ciphergen Biosystems); Austin Texas USA

3. Division of Genetic Epidemiology; Innsbruck Medical University; Innsbruck Austria

Funder

Cancer Research UK

Eve Appeal

Helen Feather Trust

Publisher

Wiley

Subject

Clinical Biochemistry

Reference49 articles.

1. International Agency for Research on Cancer (IARC) GLOBOCAN 2012 http://globocan.iarc.fr/Default.aspx

2. Screening strategies for ovarian cancer;Collins;Curr. Opin. Obstet. Gynecol.,1998

3. Diagnostic markers for early detection of ovarian cancer;Visintin;Clin. Cancer Res.,2008

4. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass;Moore;Gynecol. Oncol.,2008

5. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass;Moore;Gynecol. Oncol.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3